Author Tom Strohl issues this challenge to pharmaceutical leaders in a new white paper: Pay attention to your supply planning processes – or risk financial and regulatory peril.
“Show me a company with broken supply planning processes, and I will show you where serious compliance failures either already exist or are soon to follow,” he states.
Read this white paper to learn:
- How poorly functioning supply planning processes almost always lead to supply chain disruptions and serious compliance flaws.
Symptoms of poor supply planning processes.
How a pharmaceutical maker fixed its supply planning problems – and turned around its compliance and financial performance.